Skip to main content
CDT
NASDAQ Life Sciences

Insider Andrew Regan Buys $190K in Open Market, Increases Stake to 5.4%

Analysis by Arik Shkolnikov
Sentiment info
Positive
Importance info
9
Price
$1.9
Mkt Cap
$10.3M
52W Low
$1.775
52W High
$1,229.7
Market data snapshot near publication time

summarizeSummary

Andrew Regan, CEO of Corvus Capital Ltd., made a $190,000 open market purchase of CDT Equity Inc. shares, increasing his beneficial ownership to 5.4%.


check_boxKey Events

  • Insider Open Market Purchase

    Corvus Capital Ltd., controlled by CEO Andrew Regan, purchased 100,000 shares in the open market for $190,000 on May 13, 2026.

  • Warrant Exercise

    Corvus Capital Ltd. received 147,401 shares on March 24, 2026, through a cashless exercise of pre-funded warrants, after the 1-for-25 reverse stock split.

  • Increased Beneficial Ownership

    Andrew Regan now beneficially owns 262,766 shares, representing 5.4% of the company's outstanding common stock.


auto_awesomeAnalysis

This filing indicates a significant vote of confidence from Andrew Regan, CEO of Corvus Capital Ltd., who increased his beneficial ownership through a $190,000 open market purchase. This buying activity is particularly notable given the company's recent disclosures of a going concern warning and substantial share dilution events, suggesting strong conviction in the company's future despite financial challenges.

At the time of this filing, CDT was trading at $1.90 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $10.3M. The 52-week trading range was $1.78 to $1,229.70. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed CDT - Latest Insights

CDT
May 14, 2026, 8:47 AM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
9
CDT
May 06, 2026, 8:30 AM EDT
Source: GlobeNewswire
Importance Score:
8
CDT
May 01, 2026, 5:11 PM EDT
Filing Type: 424B3
Importance Score:
9
CDT
Apr 21, 2026, 9:56 PM EDT
Filing Type: S-3
Importance Score:
9
CDT
Apr 15, 2026, 5:01 PM EDT
Filing Type: 10-K
Importance Score:
9
CDT
Apr 02, 2026, 4:15 PM EDT
Filing Type: 424B5
Importance Score:
9
CDT
Mar 30, 2026, 9:21 PM EDT
Filing Type: SCHEDULE 13D
Importance Score:
9
CDT
Mar 26, 2026, 8:30 AM EDT
Source: GlobeNewswire
Importance Score:
8
CDT
Mar 25, 2026, 8:15 AM EDT
Filing Type: 8-K
Importance Score:
8
CDT
Mar 18, 2026, 4:53 PM EDT
Filing Type: 8-K
Importance Score:
9